legislation: 115-hr-7223
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| bill_id | congress | bill_type | bill_number | title | policy_area | introduced_date | latest_action_date | latest_action_text | origin_chamber | sponsor_name | sponsor_state | sponsor_party | sponsor_bioguide_id | cosponsor_count | summary_text | update_date | url |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 115-hr-7223 | 115 | hr | 7223 | Right Rebate Act of 2018 | Health | 2018-12-06 | 2018-12-13 | Referred to the Subcommittee on Health. | House | Rep. Schrader, Kurt [D-OR-5] | OR | D | S001180 | 1 | Right Rebate Act of 2018 This bill requires drug manufacturers with Medicaid rebate agreements for covered outpatient drugs to disclose drug product information. Manufacturers are subject to civil penalties for knowingly misclassifying drugs. Manufacturers are also required to compensate for rebates that were initially underpaid as a result of misclassification (whether or not such misclassification was committed knowingly). | 2023-01-11T13:40:51Z |